International Journal of Angiology

LinksSchließen

Referenz

Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L.
Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer's disease.

J Prev Alzheimers Dis 2018;
5 (02) 149-154

Bibliographische Angaben herunterladen

Aufrufen in: